Europe drops in premarket as coronavirus drug flops24 Apr 2020 08:30
European equities plunged in premarket trade on Friday after it was reported a potential coronavirus treatment has failed in its first randomized clinical trial. The antiviral drug remdesivir developed bi Gilead Sciences failed to improve the conditions of 158 patients carrying the virus in a Chinese trial. Gilead said the trial was terminated early.
Meanwhile, investors await more economic data, including retail sales figures for the UK and a report on Germany's business climate.
The DAX dropped 1.98% at 7:30 am CET, while the FTSE 100 fell 1.48%. At the same time, the euro declined 0.09% against the dollar, buying 1.07687.
Breaking the News / JC